Overweight and obesity have also been related to low levels of the insulin sensitiser adiponectin, and consequently to increased risk of hyperinsulinaemia and type II diabetes (Mantzoros et al, 2005). Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.